The point‐of‐care (POC) N‐terminal pro B‐type natriuretic peptide (NT‐proBNP) ELISA test has the potential to be a convenient tool for screening cats for cardiac disease in general practice (GP). This evidence concerns the gene NPPB and heart disorder.